TTM
−$284.00K
YoY change
+31.7%
5Y CAGR
—
Peak year (2021)
$65.00K
Cumulative gross profit
−$1.62M
Gross Profit history chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: −$661.00K
Gross Profit growth chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: +31.7%
Gross Profit history table for Alto Neuroscience (ANRO) from 2021 to 2025
| 2025 | −$661.00K | +31.7% | −$159.00K | ||
| 2024 | −$502.00K | — | −$502.00K | ||
| 2023 | $0.00 | -100.0% | +$342.00K | ||
| 2022 | −$342.00K | -626.2% | −$407.00K | ||
| 2021 | $65.00K | — | — |
- 2025−$661.00K+31.7%
- 2024−$502.00K—
- 2023$0.00-100.0%
- 2022−$342.00K-626.2%
- 2021$65.00K—
Gross Profit values are taken from Alto Neuroscience's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Alto Neuroscience (ANRO)
According to Alto Neuroscience's latest reported financial statements, the company's current gross profit (TTM) is −$284.00K. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Alto Neuroscience (ANRO) reported gross profit of −$661.00K – surged 31.7% year-over-year.
Between 2021 and 2025, Alto Neuroscience gross profit plunged 1116.9%, falling from $65.00K to −$661.00K.
The record annual gross profit stands at $65.00K, reached in 2021; the historical low of −$661.00K was recorded in 2025.
Alto Neuroscience Gross Profit by Year
Alto Neuroscience Gross Profit 2025: −$661.00K
In 2025, Alto Neuroscience reported gross profit of −$661.00K, surged 31.7% from 2024. This figure represents the lowest annual value in the available history.
Alto Neuroscience Gross Profit 2024: −$502.00K
Alto Neuroscience gross profit in 2024 was −$502.00K.
Alto Neuroscience Gross Profit 2023: $0.00
2023's gross profit for Alto Neuroscience came in at $0.00, plunged 100.0% below 2022.
Alto Neuroscience Gross Profit 2022: −$342.00K
Alto Neuroscience posted gross profit of −$342.00K in 2022, plunged 626.2% below 2021.
Alto Neuroscience Gross Profit 2021: $65.00K
Alto Neuroscience gross profit in 2021 was $65.00K.
See more financial history for Alto Neuroscience (ANRO).
Sector peers by Gross Profit
Healthcare peers of Alto Neuroscience (ANRO), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation